secwatch.observer — SEC 8-K summary
======================================

Issuer:     Revolution Medicines, Inc. (RVMD)
CIK:        0001628171
Form:       8-K
Filed at:   2022-07-22T23:59:59+00:00
Accession:  0001193125-22-200017
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Revolution Medicines raises $248M net in public offering of 13.225M shares at $20/share
--------------------------------------------------------------------------------

- Sold 13.225M shares (including full exercise of underwriters' option) at $20.00 per share public price.
- Net proceeds of approximately $248.0M after underwriting discounts and offering expenses.
- Underwriters include J.P. Morgan, Cowen, Guggenheim; lock-up period of 60 days for directors and officers.
- Offering closed on July 22, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628171/000119312522200017/0001193125-22-200017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628171/000119312522200017/d61456d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-200017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer